Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $198.9 million.

  • Amicus Therapeutics' Total Current Liabilities rose 2579.52% to $198.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.9 million, marking a year-over-year increase of 2579.52%. This contributed to the annual value of $148.7 million for FY2024, which is 1132.27% down from last year.
  • According to the latest figures from Q3 2025, Amicus Therapeutics' Total Current Liabilities is $198.9 million, which was up 2579.52% from $167.6 million recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Total Current Liabilities registered a high of $198.9 million during Q3 2025, and its lowest value of $99.7 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $149.9 million, with a median of $152.9 million in 2025.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 4699.58% in 2022, then crashed by 1132.27% in 2024.
  • Over the past 5 years, Amicus Therapeutics' Total Current Liabilities (Quarter) stood at $146.0 million in 2021, then dropped by 4.77% to $139.0 million in 2022, then increased by 20.62% to $167.7 million in 2023, then dropped by 11.32% to $148.7 million in 2024, then surged by 33.78% to $198.9 million in 2025.
  • Its Total Current Liabilities was $198.9 million in Q3 2025, compared to $167.6 million in Q2 2025 and $152.9 million in Q1 2025.